A phase 2 consortium (P2C) trial of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP) for advanced adenocarcinoma of the pancreas (Q34750537)
scientific article
Language:
(P31) (Q13442814)
(P50) (Q107054204)
(Q107069384)
(Q112326955)
(Q117264226)
(P304) 369-379
(P407) (Q1860)
(P433) 4
(P478) 26
(P577) Saturday, February 16, 2008
(P921) (Q42824440)
(Q9618)
(Q356033)
(P1433) (Q2312231)
(P1476) "A phase 2 consortium (P2C) trial of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP) for advanced adenocarcinoma of the pancreas" (language: en)
(P2093) Steven Attia
Jill Kolesar
Daniel Laheru
James Heun
Wei Huang
Jens Eickhoff
(P2860) (Q37304878)
(Q33375650)
(Q29619344)
(Q29547293)
(Q33243823)
(Q40283544)
(Q33367733)
(Q34557866)
(Q34550827)
(Q24673038)
(Q35642041)
(Q33357008)
(Q34156828)
(Q33344022)
(Q34525788)
(Q34522003)
(Q33181907)
(Q35113118)
(Q27860904)
(Q33724511)
(Q41089642)
(Q29547565)
(Q46579981)
(Q41455136)
(Q54350017)
(Q40213340)
(Q46956783)
(Q44875555)
(Q52030096)
(Q43705904)
(Q50927905)
(Q80059427)
(Q68248996)
(Q59647299)
(Q72114635)
(Q94516013)
(Q71528572)
other details
description scientific article

External Links